Talent
Jerry Lanese Description
The existing GMPs
were finalized in 1979 and the industry has changed considerably since that
time. In 2001 the FDA announced to the pharmaceutical industry that it would
regulate the industry based on good science and risk. Since that time the
Agency has partnered with ICH in the release of ICH Q8, Pharmaceutical
Development, ICH Q9, Risk Management and ICH Q10, The Pharmaceutical Quality
System. FDA has also issued guidances on Process Validation, Quality Metrics
and Data Integrity. All of these provide contemporary interpretation for a
quality system approach to the enforcement of the existing regulation, the drug
GMPs, 21CFR211.
Objective : The objective of this webinar is to inform personnel involved with GMP operations in a pharmaceutical firm how the FDA is transitioning the interpretation from the regulation as written in 1978 to a more modern, quality system based interpretation. Areas Covered in the Session :
In this webinar we will discuss guidances issued by the FDA since the turn of the century and how these bring a contemporary interpretation to the drug GMPs.
Guidance documents discussed will include:
The discussion will be enforced by recent observations which will be used to clarify the regulatory emphasis on science and risk and its current interpretation of the GMPS. Who Will Benefit:
The following individuals should attend this audio seminar:
About Speaker:
John G. (Jerry) Lanese is an independent consultant with a focus on Quality Systems and the components of an effective Quality System. He received a BA and MS from Middlebury College and a Ph.D. in Analytical Chemistry from the University of Michigan and began his career teaching Analytical Chemistry in a small liberal arts college. Dr. Lanese moved from the academic environment to the pharmaceutical industry where he has managed Analytical Research, Quality Control and Quality Assurance functions. In 1994 Dr. Lanese formed his own company, The Lanese Group, and since that time he has been a consultant in the area of quality system and cGMP compliance and has audited and consulted with small and large medical device and pharmaceutical companies, including companies under FDA Consent Decree, API and excipient manufacturers, electronic firms and other manufacturing organizations. Dr. Lanese focuses on training. He lectures throughout the world and presents training in all formats (lectures, seminars and webinars) on a variety of topics related to Quality Systems, GMPs, APIs, training, laboratory operations, calibration, change control, deviations and product reviews for clients and seminar, webinar and conference providers. Jerry is a member of the Editorial Board of the Journal of GXP Compliance. Event URL: https://www.compliancetrainingpanel.com/Webinar/Topic?WB=MP00106
Organizer: Compliance Training Panel Website: http://www.compliancetrainingpanel.com/Webinar/LiveEmail: support@compliancetrainingpanel.com Phone: 844-216-5230 |
Presented By
1:00pm to 2:30pm
General Admission: $239.00
21+
200 844-216-5230 UPCOMING EVENTS
PAST EVENTS
Thursday, July 12th
This is an Online Webinar Past Event
Tuesday, June 26th
Online Event Past Event
|